News - Watson Pharmaceuticals, Johnson & Johnson

Filter

Popular Filters

Actavis debuts generic Pariet in Europe; Impax challenges Opana ER patent

18-11-2012

Switzerland-based generic drugmaker Actavis, now wholly-owned by the USA's Watson Pharmaceuticals (NYSE:…

ActavisEndo PharmaceuticalsGastro-intestinalsGenericsGrunenthalImpax LaboratoriesJohnson & JohnsonMarkets & MarketingNeurologicalNorth AmericaOpana ERParietPatentsThoRx LabsWatson Pharmaceuticals

Forest files suit over Bystolic patent; generic Lexapro launched in USA

15-03-2012

US drugmaker Forest Laboratories (NYSE: FRX) and Janssen Pharmaceutica, a unit of health care giant Johnson…

BystolicCardio-vascularForest LaboratoriesGenericsJanssen PharmaceuticaJohnson & JohnsonLexaproNeurologicalNorth AmericaPatentsRegulationTeva Pharmaceutical IndustriesWatson Pharmaceuticals

Watson settles with Janssen over Ortho Tri-Cyclen LO

08-02-2012

US generic drugmaker Watson Pharmaceutical (NYSE: WPI) says that its subsidiary, Watson Laboratories,…

GenericsJanssenJohnson & JohnsonLegalNorth AmericaPatentsReproductiveWatson PharmaceuticalsWomen's Health

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top